Kurma Partners

Kurma Partners is a major player in funding healthcare and biotechnology in Europe. They work closely with research teams to create and support high-tech companies, providing capital and expertise. Kurma Partners has a strong network of partners and is committed to sustainable development and ESG practices.

Kurma Partners favicon
Founded 2009 · Venture Capital
Paris (France), Munich (Germany)
Investment Stages
Pre-Seed
Seed
Series A
Series B
Markets
Biotech
AgTech
MedTech
Diagnostics
Digital Diagnostics
Portfolio Companies

ABM, Pharmareva, Altamira Therapeutics, Amolyt Pharma, AM Pharma, Argobio Studio, Arkhn, Asarina Pharma, Asceneuron, Avidicure, Axithra, BioSerinity, BliNK, Cardiologs, Charles, Coave Therapeutics, Corlieve Therapeutics, Corteria, DAMAE Medical, Deepull, DNA Script, Emergence, Flamingo Therapeutics, Ganymed Robotics, Germitec, Hopia, ImCheck, IO Biotech, Kiro, Kurma Accélération, MedLumics, Meiogenix, Mémo Tx, Minroyx, NaoX Technologies, Omnidoc, Orphazyme, OxThera, Pantera, PathoQuest, Pharvaris, Poppins, Raidium, RyCarma, Safe Orthopaedics, SciRhom, Sensome, Shorla Oncology, Smartcatch, Spotlight Medical, StatDx, STEP Pharma, Stilla Technologies, Sunrise, Synendos Therapeutics, Tacalyx, Talix, Vico Therapeutics, Vivet Therapeutics, Xeltis, Zealand Pharma

Share this page